Streetbeat News

Revenues

BA

LMT

NOC

Anduril Industries, a U.S. defense technology startup, has raised $1.5 billion in funding, led by Peter Thiel's venture capital firm, to accelerate the production of autonomous weapons. The funding round has increased Anduril's valuation to $14 billion. The company plans to use the funds to build new manufacturing facilities, including the first factory, Arsenal-1, in the U.S. Anduril has secured contracts with the U.S. and UK military and recently won a major U.S. Air Force contract over competitors Lockheed Martin, Northrop Grumman, and Boeing.

Portfolio Pulse from Benzinga Neuro

August 09, 2024 | 10:57 am

GLD

LLY

QQQ

SPY

U.S. stock markets closed higher on August 8, with the Nasdaq and S&P 500 gaining over 2% due to a drop in jobless claims. Eli Lilly shares surged 9.5% after raising its profit forecast. Asian markets were mixed, while European markets opened in green. Commodities saw minor changes, with gold trading near its all-time high.

Portfolio Pulse from Akanksha Bakshi

August 09, 2024 | 10:49 am

CTM

Castellum reported Q2 revenue of $11.5M, up from $11.3M in Q1. Gross profit increased to $4.7M from $4.5M in Q1. Operating loss improved to $(1.6)M from $(2.7)M in Q1. Adjusted EBITDA was $0.3M, excluding non-cash charges, compared to $(0.1)M in Q1 and $0.1M in Q2 2023.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:49 am

GOOG

GOOGL

MSFT

PLTR

Palantir Technologies Inc. co-founder Joe Lonsdale supports the antitrust ruling against Google but criticizes FTC Chair Lina Khan. Lonsdale calls for more regulations to prevent big tech monopolies. Palantir expanded its partnership with Microsoft and reported strong Q2 revenue growth.

Portfolio Pulse from Ananya Gairola

August 09, 2024 | 10:45 am

ARRY

EB

ELF

FIVN

LUMN

PUBM

ZVRA

Several major stocks, including PubMatic, Eventbrite, Five9, Zevra Therapeutics, Array Technologies, e.l.f. Beauty, and Lumen Technologies, are experiencing significant declines in pre-market trading due to various factors such as worse-than-expected earnings, revenue guidance cuts, and public offerings.

Portfolio Pulse from Avi Kapoor

August 09, 2024 | 10:44 am

EMBC

Embecta has reaffirmed its 2024 revenue guidance of $1.11 billion to $1.12 billion, which is in line with the consensus estimate of $1.115 billion.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:34 am

GB

Global Blue reported a 12% growth in its Issued Sales In-Store for July in Continental Europe, indicating a positive trend in tax-free shopping.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:27 am

AIRS

AirSculpt Technologies has revised its FY24 outlook, lowering its revenue guidance to $180M-$190M from the previous $220M and reducing the number of new centers to be opened in the second half of 2024 from six to five.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:24 am

NYC

American Strategic (NYSE:NYC) reported Q2 losses of $(2.84) per share, beating the $(2.99) estimate but showing a significant year-over-year decline. Sales were $15.75M, missing the $16.06M estimate and slightly down from last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:22 am

AIRS

AirSculpt Technologies (NASDAQ:AIRS) reported Q2 earnings of $0.09 per share, beating the analyst estimate of $0.04. However, sales of $51.00 million missed the $55.26 million estimate. Earnings decreased by 30.77% year-over-year, and sales decreased by 8.44% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:20 am